CompletedNot Applicable

Phase Angle and Chronic Intestinal Inflammatory Diseases

Italy100 participantsStarted 2021-06-01

Plain-language summary

Phase angle (PhA) is a biometric parameter measured by bioimpedance analysis (BIA), which reflects organism cellularity and tissues hydration. In addition, since it correlates with the presence of inflammation and the nutritional status, it could be useful to monitor inflammatory bowel disease (IBD) activity. The aim of this study was to establish the potential use of PhA as a new non-invasive and sensitive marker correlated with mucosal healing and/or IBD activity.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * histological report confirming the diagnosis of IBD, * value of C-reactive protein (CRP) * fecal calprotectin, * colonoscopy within 3 months from the enrollment. Exclusion Criteria: * presence of ascites or edema, * chronic or autoimmune inflammatory diseases, * ongoing infections, * recent surgery (in the last 6 months), * neoplastic diseases, * ongoing enteral or parenteral nutrition, * presence of fistulae, * ileostomy or colostomy, * short bowel syndrome, * pregnancy or lactation.

What they're measuring

The correlation of phase angle with mucosal healing in patients with inflammatory bowel disease

Timeframe: At enrollment

Trial details

NCT IDNCT05106738

SponsorUniversity of Bari

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-31

View on ClinicalTrials.gov More Inflammatory Bowel Diseases trials